Assignee
ALK ABELLO AS
DK·21 granted patents·29 pending applications·79 citations·filing 1999–2023
Top patents by PatentIndex Score
50 records- 0186US10080719B2Allergen dosage formALK ABELLO AS·Filed 2016·Granted Sep 25, 2018·6 cites·23 claims
- 0281US9408805B2Allergen dosage formALK-ABELLO AS·Filed 2014·Granted Aug 9, 2016·4 cites·14 claims
- 0380US7887821B2Process for producing an allergen extractALK ABELLO AS·Filed 2007·Granted Feb 15, 2011·4 cites·16 claims
- 0478US8012505B2Dosage form having a saccharide matrixALK ABELLO AS·Filed 2004·Granted Sep 6, 2011·13 cites·26 claims
- 0574US6939681B1Method of detecting an antibody in a liquid sampleALK ABELLO AS·Filed 2002·Granted Sep 6, 2005·15 cites·17 claims
- 0671US7785611B2Parenteral vaccine formulations and uses thereofALK ABELLO AS·Filed 2005·Granted Aug 31, 2010·4 cites·20 claims
- 0765US7691972B2Crystal structure of house dust mite allergen Der p 1ALK ABELLO AS·Filed 2005·Granted Apr 6, 2010·2 cites·2 claims
- 0864US7384635B2Protein variants of naturally occurring allergensALK ABELLO AS·Filed 2003·Granted Jun 10, 2008·3 cites·5 claims
- 0963US10059751B2Peptide combinations and uses thereof in treating dust mite allergyALK ABELLO AS·Filed 2014·Granted Aug 28, 2018·1 cites·15 claims
- 1062US2010291155A1Allergy vaccine composition for mucosal administrationALK ABELLO AS·Filed 2009·Application pending·0 cites
- 1161US10842866B2Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereofALK ABELLO AS·Filed 2019·Granted Nov 24, 2020·0 cites·24 claims
- 1258US10874736B2Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereofALK ABELLO AS·Filed 2016·Granted Dec 29, 2020·0 cites·11 claims
- 1358US2020123213A1Immunogenic proteins and fragments thereof from allergenic mitesALK ABELLO AS·Filed 2019·Application pending·0 cites
- 1456US2009054625A1Recombinant protein variantsALK ABELLO AS·Filed 2008·Application pending·0 cites
- 1556US2025295655A1Bruton's kinase inhibitors for the treatment of a sudden allergic reactionALK ABELLO AS·Filed 2023·Application pending·0 cites
- 1656US2025325658A1Peanut allergen compositionsALK ABELLO AS·Filed 2023·Application pending·0 cites
- 1755US10556936B2Immunogenic proteins and fragments thereof from allergenic mitesALK ABELLO AS·Filed 2017·Granted Feb 11, 2020·0 cites·11 claims
- 1854US10471008B2Allergen dosage formALK ABELLO AS·Filed 2017·Granted Nov 12, 2019·0 cites·26 claims
- 1950US7867715B2Method of evaluating the immunological activity of a vaccineALK ABELLO AS·Filed 2004·Granted Jan 11, 2011·1 cites·26 claims
- 2049US10023900B2Method for quantification of allergensALK ABELLO AS·Filed 2014·Granted Jul 17, 2018·0 cites·7 claims
- 2149US9657070B2Recombinant allergenALK-ABELLO AS·Filed 2013·Granted May 23, 2017·0 cites·17 claims
- 2249US2011200641A1Minor allergen control to increase safety of immunotherapyALK ABELLO AS·Filed 2011·Application pending·0 cites
- 2349US2010086569A1Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergenALK ABELLO AS·Filed 2008·Application pending·0 cites
- 2448US7968351B2Method for dissolution testing of pharmaceutical productsALK ABELLO AS·Filed 2006·Granted Jun 28, 2011·1 cites·30 claims
- 2548US2003103938A1Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratioALK ABELLO AS·Filed 2002·Application pending·0 cites
- 2648US2006210590A1Minor allergen control to increase safety of immunotherapyALK ABELLO AS·Filed 2006·Application pending·0 cites
- 2747US6379909B1Method of detecting an antibody in a liquid sampleALK ABELLO AS·Filed 1999·Granted Apr 30, 2002·13 cites·28 claims
- 2846US2025339620A1AutoinjectorALK ABELLO AS·Filed 2023·Application pending·0 cites
- 2946US2009155351A1Solid Vaccine FormulationALK ABELLO AS·Filed 2006·Application pending·0 cites
- 3046US2014127298A1Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen seasonALK ABELLO AS·Filed 2014·Application pending·0 cites
- 3145US2010240098A1Process for producing mature recombinant mite group i allergenALK ABELLO AS·Filed 2008·Application pending·0 cites
- 3243US2004071717A1Recombinant DNA encoding the major allergen of plantago lanceolata pollen, Pla I 1, and applications thereofALK ABELLO AS·Filed 2002·Application pending·0 cites
- 3343US2002051794A1Novel parenteral vaccine formulations and uses thereofALK ABELLO AS·Filed 2001·Application pending·0 cites
- 3443US2004091500A1Recombinant allergensALK ABELLO AS·Filed 2003·Application pending·0 cites
- 3541US2004043438A1Allergen mutantsALK ABELLO AS·Filed 2003·Application pending·0 cites
- 3641US2010236973A1Container For a Blister PackageALK ABELLO AS·Filed 2007·Application pending·0 cites
- 3741US2008254058A1Pharmaceutical Composition Comprising a Bacterial Cell Displaying a Heterologous Proteinaceous CompoundALK ABELLO AS·Filed 2005·Application pending·0 cites
- 3841US2006002962A1Method of treating allergy and infection by eliciting an IGA antibody responseALK ABELLO AS·Filed 2005·Application pending·0 cites
- 3940US2005202030A1Method of evaluating the therapeutic potential of a vaccine for mucosal administrationALK ABELLO AS·Filed 2005·Application pending·0 cites
- 4039US2003175312A1Novel mutant allergensALK ABELLO AS·Filed 2001·Application pending·0 cites
- 4138US2011052639A1Allergen mutantsALK ABELLO AS·Filed 2010·Application pending·0 cites
- 4237US2013008818A1Container for a blister packageALK ABELLO AS·Filed 2012·Application pending·0 cites
- 4334US2006171968A1Method of preventive treatment of allergy by oromucosal administration of an allergy vaccineALK ABELLO AS·Filed 2006·Application pending·0 cites
- 4432US7759133B2Method of detecting and/or quantifying a specific IgE antibody in a liquid sampleALK ABELLO AS·Filed 1999·Granted Jul 20, 2010·12 cites·22 claims
- 4532US2005232930A1Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen productALK ABELLO AS·Filed 2004·Application pending·0 cites
- 4630US2015126459A1Plant profilin polypeptides for use in non-specific allergy immunotherapyALK ABELLO AS·Filed 2013·Application pending·0 cites
- 4729US11020527B2Injector comprising a safety pinALK ABELLO AS·Filed 2016·Granted Jun 1, 2021·0 cites·18 claims
- 4829US11013781B2Peptide combinations and uses thereof for treating grass allergyALK ABELLO AS·Filed 2016·Granted May 25, 2021·0 cites·9 claims
- 4924US2006121064A1Method of preventive treatment of allergy by mucosal administration of an allergy vaccineALK ABELLO AS·Filed 2005·Application pending·0 cites
- 5024US2006115499A1Liquid allergy vaccine formulation for oromucosal administrationALK ABELLO AS·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →